Abstract
Objectives Cell salvage and retransfusion of autologous blood has been shown to reduce the requirement for homologous blood transfusion during cardiac surgery. The adverse effects of blood transfusion are well-documented. Different techniques have been developed in the past to reduce homologous blood transfusion requirement. We evaluated the advantages of cell saver processed red blood cells which were to be used as autologous blood transfusion intra operatively and tried to avoid allogenic blood transfusion. We studied the safety and efficacy of this technique and determined the effects on haematological parameters, clotting parameters, homologous blood transfusion requirements, blood loss and postoperative parameters.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Indian Journal of Thoracic and Cardiovascular Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
